Free Next Day Delivery on orders of $500 or more — Shop All Peptides

IN Peptides copy
0
Buy PNC-27

PNC-27 – 10mg

$125.00

PNC-27

PNC-27 is a synthetic peptide that researchers have investigated its potential to selectively target cells by binding to a specific protein found on the surface of tumor cells, triggering cell death. PNC-27 is particularly notable for its ability to penetrate cell membranes and induce apoptosis, which makes it a subject of growing interest in research.

Potential Research Applications

PNC-27 is currently being explored in research settings for its role in:

  • Tumor Suppression & Apoptosis: Researched for its role in stimulating apoptosis by interacting with the cell membranes of cells and triggering cell death mechanisms.
  • Targeted Drug Delivery: Explored for its potential to serve as a delivery vehicle, improving the efficacy and specificity of therapeutic agents.
  • Oncolytic Applications: Investigated for its potential in oncolytic treatments, where the peptide may aid in breaking down bad cells while sparing healthy ones.

✔ High-Quality Research Peptide – Produced under stringent quality control standards.
✔ Lab-Tested for Purity – Ensures consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Will arrive in a lyophilized (powder) form for maximum stability.

Buy Peptides Online

The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.

  • Description
  • Certificate of Analysis

PNC-27 is a synthetic peptide. It comes from a part of the p53 tumor suppressor protein. p53 controls the cell cycle, repairs DNA, and triggers apoptosis. Researchers designed PNC-27 to kill abnormal cells. Meanwhile, healthy cells remain unaffected.

PNC-27 binds to HDM-2. HDM-2 normally blocks p53. p53 stops tumor growth by halting the cell cycle or inducing apoptosis. However, HDM-2 often prevents p53 from working. By binding HDM-2, PNC-27 restores p53. Consequently, it kills abnormal cells and slows tumor growth.

PNC-27 shows potential in targeting abnormal cells. For example, it affects breast, prostate, and pancreatic tissues. In addition, it selectively recognizes abnormal cell membranes. Therefore, it delivers the peptide to target tissues while sparing healthy cells.

Moreover, PNC-27 directly targets abnormal cells. This quality has sparked interest in its use as a therapeutic agent. Preclinical studies show that PNC-27 induces tumor regression. It may also work with existing treatments. However, further studies and clinical trials are needed to prove its safety and effectiveness.

Currently, scientists use PNC-27 in labs to study its action and potential. They focus on its ability to trigger apoptosis and bind to HDM-2. Furthermore, they explore its synergy with other treatments. It is not approved for human use. Its clinical development remains in early stages.

For Research Use Only.

No Certificate of Analysis images available for this product.

Frequently bought together

Skip to content